Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison sedative effect of dexmedetomidine and midazolam in gastrointestinal endosonography
IRCT20190417043295N1Phase 4Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and midazolam in anxiety disorder (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Sedative effect comparison. Started Apr 2019; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20190417043295N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190417043295N1.